| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/09/2014 | CN101597326B kahalalide F 及相关化合物 kahalalide F and related compounds |
| 07/09/2014 | CN101198340B 转移因子制品及相关的方法 Transfer factor products and related methods |
| 07/08/2014 | USRE45003 Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae |
| 07/08/2014 | US8772469 Synthetic double-stranded oligonucleotides for specific inhibition of gene expression |
| 07/08/2014 | US8772449 Cell-penetrating peptides |
| 07/08/2014 | US8772448 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis |
| 07/08/2014 | US8772446 Bifunctional chelating agents |
| 07/08/2014 | US8772445 Production and use of antitumoral cyclodepsipeptides |
| 07/08/2014 | US8772263 Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions |
| 07/08/2014 | US8772261 Treatment of tumors with genetically engineered herpes virus |
| 07/08/2014 | US8772250 Compositions and methods for treating ischemia and ischemia-reperfusion injury |
| 07/08/2014 | US8772249 Compositions and methods for treating ischemia and ischemia-reperfusion injury |
| 07/08/2014 | US8772248 Drug delivery system |
| 07/08/2014 | US8772247 Anti-parasitic compounds |
| 07/08/2014 | US8772246 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/08/2014 | US8772245 Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof |
| 07/08/2014 | US8772244 Tubulin inhibitors |
| 07/08/2014 | US8772243 Methods for predicting the response to anti-cancer treatment with an agonist of TLR7 or an agonist of TLR8 |
| 07/08/2014 | US8772242 Therapy for enteric infections |
| 07/08/2014 | US8772241 Peptide and use thereof |
| 07/08/2014 | US8772240 Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidases |
| 07/08/2014 | US8772239 Medicament for therapeutic treatment and/or improvement of sepsis |
| 07/08/2014 | US8772238 Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer |
| 07/08/2014 | US8772237 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 07/08/2014 | US8772236 Truncated cystine-knot proteins |
| 07/08/2014 | US8772235 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof |
| 07/08/2014 | US8772234 BMP10 propeptides and related methods |
| 07/08/2014 | US8772233 Method for promoting regeneration of pancreatic beta-cells by administering neurturin |
| 07/08/2014 | US8772232 Protracted exendin-4 compounds |
| 07/08/2014 | US8772231 Stabilizing alkylglycoside compositions and methods thereof |
| 07/08/2014 | US8772230 Niacin and/or trigonelline as a muscle stimulant |
| 07/08/2014 | US8772229 Methods for synthesis and uses of inhibitors of ghrelin O-acyltransferase as potential therapeutic agents for obesity and diabetes |
| 07/08/2014 | US8772228 Aligned nanofibers and related methods of use |
| 07/08/2014 | US8772226 Methods and compositions for the detection of cancer |
| 07/08/2014 | US8772225 Biomarkers for multiple sclerosis |
| 07/08/2014 | US8771973 Methods for treating bleeding disorders using sulfated polysaccharides |
| 07/08/2014 | US8771965 Methods and compositions involving nucleotide repeat disorders |
| 07/08/2014 | US8771945 CRISPR-Cas systems and methods for altering expression of gene products |
| 07/08/2014 | US8771752 Composition for preventing and treating fatty liver |
| 07/08/2014 | US8771737 Compositions for regenerating defective or absent myocardium |
| 07/08/2014 | US8771728 Stable lipid-comprising drug delivery complexes and methods for their production |
| 07/08/2014 | US8771707 Botulinum neurotoxin E receptors and uses thereof |
| 07/08/2014 | US8771701 Compositions for immunotherapy and uses thereof |
| 07/08/2014 | US8771700 Interferon antagonists, antibodies thereto and associated methods of use |
| 07/08/2014 | US8771698 Modulation of UL24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection |
| 07/08/2014 | US8771696 Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor |
| 07/08/2014 | US8771691 Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma |
| 07/08/2014 | US8771689 Alpha B-crystallin as a therapy for ischemia or inflammation |
| 07/08/2014 | US8771684 Method of using salmon thrombin to alleviate pain |
| 07/08/2014 | US8771683 Therapeutic apyrase constructs, apyrase agents, and production methods |
| 07/08/2014 | US8771682 Methods and compositions for reducing interleukin-4 or interleukin-13 signaling |
| 07/08/2014 | US8771681 Methods and compositions for protecting and treating muscarinic receptors by administering a pyrophosphate analog to a subject exposed to bacterial, fungal, viral, prion or algal infection |
| 07/08/2014 | US8771680 Topical co-enzyme Q10 formulations and methods of use |
| 07/08/2014 | US8771679 Prodrug activation in cancer cells using molecular switches |
| 07/08/2014 | US8771676 Agrochemically active microbial formulation |
| 07/08/2014 | US8771671 Induced activation in dendritic cells |
| 07/08/2014 | US8771670 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof |
| 07/08/2014 | US8771666 Ex-vivo treatment of T-cells with IFN-λ |
| 07/08/2014 | US8771665 Inhibitors of hepatitis C virus polymerase |
| 07/08/2014 | US8771664 Compositions comprising apolipoprotein A polypeptide and interleukin 15, and methods of treatment using the same |
| 07/08/2014 | US8771663 Formulation having mobilising activity |
| 07/08/2014 | US8771650 Inducible release vehicles |
| 07/08/2014 | US8771649 Inducible release vehicles |
| 07/08/2014 | CA2819705C Method of regulating glucose metabolism, and reagents related thereto |
| 07/08/2014 | CA2784240C Stable bortezomib formulations |
| 07/08/2014 | CA2731090C Compositions and methods for treating disorders associated with overweight animals |
| 07/08/2014 | CA2724540C Treating dyspnea associated with acute heart failure with relaxin |
| 07/08/2014 | CA2652759C Nanoparticles for providing immune responses against infectious agents |
| 07/08/2014 | CA2650341C Augmentation of titer for vaccination in animals |
| 07/08/2014 | CA2647986C Compositions for tumor growth control |
| 07/08/2014 | CA2643722C Use of the engrailed homeodomain protein as an anxiolytic |
| 07/08/2014 | CA2638759C Protective complement proteins and age-related macular degeneration |
| 07/08/2014 | CA2619443C Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same |
| 07/08/2014 | CA2609221C A peptide ligand to impair cancer cell migration |
| 07/08/2014 | CA2599304C Cell targeting conjugates |
| 07/08/2014 | CA2519131C Ligands for tgf-beta binding proteins and uses thereof |
| 07/08/2014 | CA2513711C Process for the preparation of hypoallergenic mosaic antigens |
| 07/08/2014 | CA2507450C Use of a histone deacetylase inhibitor for treating muscular dystrophies |
| 07/08/2014 | CA2498725C Method of purifying polypeptides by simulated moving bed chromatography |
| 07/08/2014 | CA2495082C Methods and compositions for improving growth of meat-type poultry |
| 07/08/2014 | CA2480712C Chondrocyte therapeutic delivery system |
| 07/08/2014 | CA2472633C S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 07/08/2014 | CA2469370C Adipose-derived cell processing unit |
| 07/08/2014 | CA2463816C Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 07/08/2014 | CA2444959C Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 07/08/2014 | CA2431800C Peptide yy and peptide yy agonists for treatment of metabolic disorders |
| 07/08/2014 | CA2417568C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 07/08/2014 | CA2415422C Chromosome 3p21.3 genes are tumor suppressors |
| 07/08/2014 | CA2395369C Cytokine zcyto18 |
| 07/08/2014 | CA2372821C Antimicrobial theta defensins and methods of using same |
| 07/08/2014 | CA2350395C Nucleotide and protein sequences of nogo genes and methods based thereon |
| 07/08/2014 | CA2309810C Erythropoietin with high specific activity |
| 07/08/2014 | CA1341639C Recombinant fibroblast growth factors |
| 07/03/2014 | WO2014106116A2 Delivery of biologic therapeutics |
| 07/03/2014 | WO2014106091A1 Solution for preserving vascular conduits |
| 07/03/2014 | WO2014105913A1 Cellular compositions for tissue engineering |
| 07/03/2014 | WO2014105822A1 Administration of recombinant collagen 7 for the treatment of age related disorders |
| 07/03/2014 | WO2014105784A1 Short-acting factor vii polypeptides |
| 07/03/2014 | WO2014105644A1 Nanoparticle compositions of albumin and paclitaxel |
| 07/03/2014 | WO2014104981A1 Self-assembled ultrashort peptides hydrogels for wound healing, skin care and cosmetics applications |